Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 196 of the 197 references it cites were found in a registry or an index.

Genomic correlates of response to immune checkpoint blockade

Open access
Keenan, Tanya E., Burke, Kelly P., Van Allen, Eliezer M.·2019·Nature Medicine

Abstract

Despite impressive durable responses, immune checkpoint inhibitors do not provide a long-term benefit to the majority of patients with cancer. Understanding genomic correlates of response and resistance to checkpoint blockade may enhance benefits for patients with cancer by elucidating biomarkers for patient stratification and resistance mechanisms for therapeutic targeting. Here we review emerging genomic markers of checkpoint blockade response, including those related to neoantigens, antigen presentation, DNA repair, and oncogenic pathways. Compelling evidence also points to a role for T cell functionality, checkpoint regulators, chromatin modifiers, and copy-number alterations in mediating selective response to immune checkpoint blockade. Ultimately, efforts to contextualize genomic correlates of response into the larger understanding of tumor immune biology will build a foundation for the development of novel biomarkers and therapies to overcome resistance to checkpoint blockade.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-019-0382-x

Cites

196 of 196 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 197 references

Cited by

See all 452

Metadata

Authors
Keenan, T. E., Burke, K. P., & Van Allen, E. M.
Affiliations
  • Broad Institute (US)
  • Harvard University (US)
Venue
Nature Medicine
Published
2019-03
Volume
25
Issue
3
Pages
389-402
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2920270836
Cited by
448
References
197
Citations by year
2026: 10 · 2025: 39 · 2024: 52 · 2023: 51 · 2022: 86 · 2021: 98 · 2020: 87 · 2019: 25
FWCI
7.05
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Bristol-Myers Squibb
  • National Cancer Institute (K08CA188615, R01CA227388, U01CA233100)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
immune checkpoint inhibitors, immune checkpoint blockade response, tumor immune microenvironment, neoantigens, antigen presentation, DNA repair, oncogenic signaling, T cell function, chromatin modifiers, copy number alterations, biomarkers, resistance mechanisms, patient stratification
MeSH terms
Antineoplastic Agents, Immunological, Antigens, Neoplasm, DNA Repair, Humans, Mutation, Neoplasms, T-Lymphocytes, Signal Transduction, Genome, Antigen Presentation, Drug Resistance, Neoplasm, Chromatin Assembly and Disassembly, DNA Copy Number Variations, B7-H1 Antigen, CTLA-4 Antigen, Programmed Cell Death 1 Receptor, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genomic correlates of response to immune checkpoint blockade. https://app.cochat.ai/papers/10.1038/s41591-019-0382-x
The paper
Keenan, T. E., Burke, K. P., & Van Allen, E. M. (2019). Genomic correlates of response to immune checkpoint blockade. Nature Medicine. https://doi.org/10.1038/s41591-019-0382-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.